Great Point Partners LLC Top Holdings and 13F Report (2025) About Great Point Partners LLCInvestment ActivityGreat Point Partners LLC has $188.80 million in total holdings as of March 31, 2025.Great Point Partners LLC owns shares of 32 different stocks, but just 19 companies or ETFs make up 80% of its holdings.Approximately 30.78% of the portfolio was purchased this quarter.About 20.51% of the portfolio was sold this quarter.This quarter, Great Point Partners LLC has purchased 26 new stocks and bought additional shares in 6 stocks.Great Point Partners LLC sold shares of 8 stocks and completely divested from 4 stocks this quarter.Largest Holdings Cytokinetics $14,870,300KalVista Pharmaceuticals $11,705,795Evolus $11,365,258ABIVAX SA $10,238,194Viridian Therapeutics $10,110,000 Largest New Holdings this Quarter 00972D105 - Akebia Therapeutics $9,549,773 Holding04351P101 - Ascendis Pharma A/S $7,793,000 Holding03237H101 - Amylyx Pharmaceuticals $6,414,466 Holding45258J102 - Immunovant $6,408,750 Holding86627T108 - Summit Therapeutics $4,822,500 Holding Largest Purchases this Quarter Akebia Therapeutics 4,973,840 shares (about $9.55M)Ascendis Pharma A/S 50,000 shares (about $7.79M)Amylyx Pharmaceuticals 1,811,996 shares (about $6.41M)Immunovant 375,000 shares (about $6.41M)Summit Therapeutics 250,000 shares (about $4.82M) Largest Sales this Quarter KalVista Pharmaceuticals 772,636 shares (about $8.92M)Ionis Pharmaceuticals 255,007 shares (about $7.69M)Dynavax Technologies 264,121 shares (about $3.43M)HELIX ACQUISITION CORP II 126,167 shares (about $1.43M)Voyager Therapeutics 200,476 shares (about $677.61K) Sector Allocation Over TimeMap of 500 Largest Holdings ofGreat Point Partners LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCYTKCytokinetics$14,870,300$401,900 ▲2.8%370,0007.9%MedicalKALVKalVista Pharmaceuticals$11,705,795$8,916,219 ▼-43.2%1,014,3676.2%MedicalEOLSEvolus$11,365,258$592,105 ▲5.5%944,7436.0%MedicalABIVAX SA$10,238,194$65,075 ▼-0.6%1,638,1115.4%SPONSORED ADSVRDNViridian Therapeutics$10,110,0000.0%750,0005.4%MedicalMRUSMerus$9,981,896$3,327,804 ▲50.0%237,1565.3%MedicalAKBAAkebia Therapeutics$9,549,773$9,549,773 ▲New Holding4,973,8405.1%MedicalXENEXenon Pharmaceuticals$8,228,8760.0%245,2724.4%MedicalASNDAscendis Pharma A/S$7,793,000$7,793,000 ▲New Holding50,0004.1%MedicalDVAXDynavax Technologies$7,728,551$3,425,650 ▼-30.7%595,8794.1%MedicalIONSIonis Pharmaceuticals$7,542,500$7,693,561 ▼-50.5%250,0004.0%MedicalAMLXAmylyx Pharmaceuticals$6,414,466$6,414,466 ▲New Holding1,811,9963.4%MedicalIMVTImmunovant$6,408,750$6,408,750 ▲New Holding375,0003.4%MedicalUNCYUnicycive Therapeutics$6,312,4020.0%10,980,0003.3%MedicalNEUROGENE INC$5,514,988$330,257 ▲6.4%470,9642.9%COMDIANTHUS THERAPEUTICS INC$4,988,5000.0%275,0002.6%COMSMMTSummit Therapeutics$4,822,500$4,822,500 ▲New Holding250,0002.6%MedicalLEGNLegend Biotech$4,690,483$4,690,483 ▲New Holding138,2402.5%MedicalPCVXVaxcyte$4,361,922$4,361,922 ▲New Holding115,5172.3%MedicalAUTLAutolus Therapeutics$4,229,811$434,747 ▼-9.3%2,728,9102.2%MedicalHELIX ACQUISITION CORP II$4,224,313$1,425,687 ▼-25.2%373,8332.2%CL A ORD SHSZURAZura Bio$4,089,5500.0%3,170,1942.2%MedicalBEAMBeam Therapeutics$3,428,726$3,428,726 ▲New Holding175,5621.8%MedicalACLXArcellx$2,952,000$2,952,000 ▲New Holding45,0001.6%MedicalMREOMereo BioPharma Group$2,868,750$281,250 ▲10.9%1,275,0001.5%MedicalCNTXContext Therapeutics$2,866,4310.0%4,683,7111.5%MedicalRZLTRezolute$2,415,822$612,329 ▲34.0%833,0421.3%MedicalCNTACentessa Pharmaceuticals$2,152,715$2,152,715 ▲New Holding149,7021.1%MedicalVYGRVoyager Therapeutics$2,116,810$677,609 ▼-24.2%626,2751.1%MedicalPMNProMIS Neurosciences$1,839,6870.0%2,645,1281.0%MedicalUPSTREAM BIO INC$1,836,0000.0%300,0001.0%COMPLRXPliant Therapeutics$1,147,500$276,750 ▼-19.4%850,0000.6%MedicalJASPER THERAPEUTICS INC$0$6,892,484 ▼-100.0%00.0%COM NEWORUKA THERAPEUTICS INC$0$4,436,490 ▼-100.0%00.0%COMOPTINOSE INC$0$2,473,397 ▼-100.0%00.0%COM NEWURGNUroGen Pharma$0$2,000,528 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
